NexgenRx Inc.
NEGXF
$0.33
$0.0622.04%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 781.03% | -130.29% | 67.59% | -30.44% | 1,964.47% |
| Total Depreciation and Amortization | 14.55% | -78.55% | -2.53% | 6.67% | 146.91% |
| Total Amortization of Deferred Charges | -23.94% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -102.00% | 5,459.82% | 2.61% | -27.78% | -101.52% |
| Change in Net Operating Assets | -178.02% | 25,556.00% | -101.82% | 182.78% | 20.69% |
| Cash from Operations | -97.67% | 203.10% | -14.94% | 205.98% | -35.33% |
| Capital Expenditure | -- | 100.00% | 98.55% | -687.76% | -15.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,871.43% | 101.86% | 56.86% | -103.73% | 61.63% |
| Cash from Investing | -299.18% | 160.40% | 85.26% | -311.41% | 49.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -81.88% | 52.08% | 15.29% | 0.00% | -9.68% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 93.22% | -23.96% | -0.43% | -1,121.30% | 92.92% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 88.38% | -18.67% | 0.75% | -553.96% | 86.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.81% | 441.37% | 71.75% | 30.21% | 233.33% |